» Articles » PMID: 7683428

Characterization of a High-affinity Galanin Receptor in the Rat Anterior Pituitary: Absence of Biological Effect and Reduced Membrane Binding of the Antagonist M15 Differentiate It from the Brain/gut Receptor

Overview
Specialty Science
Date 1993 May 1
PMID 7683428
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Structure-activity studies demonstrate that galanin fragments 1-15 and 2-29 are fully active, whereas fragment 3-29 has been reported to be inactive, in a number of different in vivo models. M15, a chimeric peptide comprising galanin 1-13 and substance P5-11, has recently been found to be a potent galanin antagonist. Direct effects of galanin at the level of the pituitary have been defined, yet, paradoxically, a number of studies have been unable to demonstrate galanin binding to an anterior pituitary receptor. Porcine galanin stimulated prolactin release from dispersed rat anterior pituitary cells up to 180% +/- 12% (mean +/- SEM) of control secretion. The addition of a specific galanin antiserum caused a profound inhibition of basal prolactin release, maximal inhibition being 12% +/- 0.5% of control secretion. Addition of M15 produced no effect on basal or galanin-stimulated prolactin release. Galanin fragment 3-29 was fully active when compared to galanin 1-29. Fragments 5-29 and 8-29 stimulated prolactin release to a lesser extent and galanin 1-15, 10-29, and 20-29 had no significant prolactin-releasing activity. Using [mono(125I)iodo-Tyr26]galanin or porcine 125I-labeled Bolton-Hunter [mono(125I)iodo-Lys25]galanin, no anterior pituitary membrane binding was observed. In contrast, 125I-labeled Bolton-Hunter N-terminally labeled galanin allowed characterization of a single high-affinity anterior pituitary galanin receptor with a Kd of 4.4 +/- 0.34 nM and a Bmax of 79 +/- 8.3 fmol/mg of protein. The IC50 for porcine galanin was 0.51 +/- 0.04 nM but for M15 was in excess of 10 microM. Galanin 3-29 fully displaced the label with an IC50 of 0.96 +/- 0.7 nM. The IC50 for galanin 5-29 was 200 nM, whereas 8-29 and 1-15 were > 1 microM. Galanin 10-29 and 20-29 failed to displace the label. These data suggest the presence of a high-affinity pituitary galanin receptor, designated GAL-R2, in which region 3-10 and amino acid 25 are crucial for membrane binding and biological activity, in contrast to the known gut/brain galanin receptor (designated GAL-R1). A number of tissues known to bind or respond to galanin were screened. GAL-R2 would appear to be expressed only in the anterior pituitary and hypothalamus.

Citing Articles

Coordinated Targeting of Galanin Receptors on Cholangiocytes and Hepatic Stellate Cells Ameliorates Liver Fibrosis in Multidrug Resistance Protein 2 Knockout Mice.

Petrescu A, Grant S, Williams E, Frampton G, Parks N, Blaney H Am J Pathol. 2020; 190(3):586-601.

PMID: 31953035 PMC: 7074378. DOI: 10.1016/j.ajpath.2019.10.023.


The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Alexander S, Benson H, Faccenda E, Pawson A, Sharman J, Spedding M Br J Pharmacol. 2014; 170(8):1459-581.

PMID: 24517644 PMC: 3892287. DOI: 10.1111/bph.12445.


Alarin stimulates food intake and gonadotrophin release in male rats.

Boughton C, Patterson M, Bewick G, Tadross J, Gardiner J, Beale K Br J Pharmacol. 2010; 161(3):601-13.

PMID: 20880399 PMC: 2990158. DOI: 10.1111/j.1476-5381.2010.00893.x.


Stimulation of anterior pituitary galanin and prolactin gene expression in suckling rats.

Ren J, Koenig J, Hooi S Endocrine. 2000; 11(3):251-6.

PMID: 10786821 DOI: 10.1385/ENDO:11:3:251.


Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland.

Spady T, McComb R, Shull J Endocrine. 2000; 11(3):217-33.

PMID: 10786818 DOI: 10.1385/ENDO:11:3:217.


References
1.
Tatemoto K, Rokaeus A, Jornvall H, McDonald T, Mutt V . Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett. 1983; 164(1):124-8. DOI: 10.1016/0014-5793(83)80033-7. View

2.
Gregersen S, Hermansen K, Langel U, Fisone G, Bartfai T, Ahren B . Galanin-induced inhibition of insulin secretion from rat islets: effects of rat and pig galanin and galanin fragments and analogues. Eur J Pharmacol. 1991; 203(1):111-4. DOI: 10.1016/0014-2999(91)90797-t. View

3.
Skofitsch G, Jacobowitz D . Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides. 1985; 6(3):509-46. DOI: 10.1016/0196-9781(85)90118-4. View

4.
Chng J, Christofides N, Anand P, Gibson S, Allen Y, Su H . Distribution of galanin immunoreactivity in the central nervous system and the responses of galanin-containing neuronal pathways to injury. Neuroscience. 1985; 16(2):343-54. DOI: 10.1016/0306-4522(85)90007-7. View

5.
Ottlecz A, Samson W, McCANN S . Galanin: evidence for a hypothalamic site of action to release growth hormone. Peptides. 1986; 7(1):51-3. DOI: 10.1016/0196-9781(86)90060-4. View